US Patent 11530237 Compositions and methods for treating CNS disorders
Patent 11530237 was granted and assigned to SAGE Therapeutics on December, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11530237 Compositions and methods for treating CNS disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
